Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (2) Berruezo Llacuna, Maria (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Costanza, Mariantonia Dr. (1) Diecke, Sebastian Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Gerhardt, Holger Prof. Dr. (1) Graf, Robin Dr. (2) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Janz, Martin Dr. (9) Kastelic, Nicolai (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (2) Kocks, Christine Dr. (1) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (2) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Mertins, Philipp Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rehm, Armin Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (15) Uyar, Bora Dr. (1) Willnow, Thomas Prof. Dr. (1) Zauber, Henrik Dr. (4) (-) Mathas, Stephan Dr. (8) (-) Rajewsky, Klaus Prof. Dr. (1) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) (-) 2004 (2) 2005 (2) 2006 (4) (-) 2007 (3) 2008 (4) 2009 (3) 2010 (3) 2011 (4) 2012 (2) 2013 (1) 2014 (4) 2015 (6) 2016 (3) 2017 (3) (-) 2018 (1) 2019 (2) (-) 2020 (3) 2021 (3) 2022 (4) 2023 (8) 2024 (1) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (9) Genome Engineering & Disease Models (2) Immune Regulation and Cancer (10) Mechanism-based Cancer Therapies (2) Molecular Immunology and Gene Therapy (2) Proteomics (1) Systems Biology of Gene Regulatory Elements (3) Transgenics (2) 9 Results: Active Filter: Mathas, Stephan Dr.Rajewsky, Klaus Prof. Dr.Biology of Malignant Lymphomas2004200720182020 Sort: Result score Newest to oldest Oldest to newest October 01, 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas January 01, 2004 / Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken March 01, 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto May 01, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas April 19, 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken September 01, 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas June 01, 2020 / JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert December 01, 2020 / Front Immunol B-cell-specific Myd88 L252P expression causes a premalignant gammopathy resembling IgM MGUS K. Schmidt U. Sack R. Graf W. Winkler O. Popp P. Mertins T. Sommermann C. Kocks K. Rajewsky December 17, 2020 / Blood Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S. Reinke P.J. Bröckelmann I. Iaccarino M. Garcia-Marquez S. Borchmann F. Jochims M. Kotrova K. Pal M. Brüggemann E. Hartmann S. Sasse C. Kobe S. Mathas M. Soekler U. Keller M. Bormann A. Zimmermann J. Richter M. Fuchs B. von Tresckow P. Borchmann H. Schlößer M. von Bergwelt-Baildon A. Rosenwald A. Engert W. Klapper
October 01, 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
January 01, 2004 / Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken
March 01, 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
May 01, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
April 19, 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
September 01, 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
June 01, 2020 / JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert
December 01, 2020 / Front Immunol B-cell-specific Myd88 L252P expression causes a premalignant gammopathy resembling IgM MGUS K. Schmidt U. Sack R. Graf W. Winkler O. Popp P. Mertins T. Sommermann C. Kocks K. Rajewsky
December 17, 2020 / Blood Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S. Reinke P.J. Bröckelmann I. Iaccarino M. Garcia-Marquez S. Borchmann F. Jochims M. Kotrova K. Pal M. Brüggemann E. Hartmann S. Sasse C. Kobe S. Mathas M. Soekler U. Keller M. Bormann A. Zimmermann J. Richter M. Fuchs B. von Tresckow P. Borchmann H. Schlößer M. von Bergwelt-Baildon A. Rosenwald A. Engert W. Klapper